Home › NDC Lookup › RxCUI directory › RxCUI 1191359

Fluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML Topical Cream — RxCUI 1191359

RxNorm drug concept · Semantic clinical drug
RxCUI 1191359 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1191359
Official nameFluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluocinolone acetonide 0.025 % / neomycin sulfate 0.5 % Topical Cream
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,908 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluocinolone Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The fluocinolone acetonide oil covered here treats atopic dermatitis (eczema) in adults. It is also used for moderate to severe eczema in children 3 months and older, for up to 4 w...
  • Use a thin film on the affected skin only, and just enough to cover it. Adults use it about three times a day. For children, moisten the skin first and apply about twice a day. Kee...
  • Not unless your doctor directs it. Avoid the face, underarms, groin and skin folds. Never use it in the diaper area, because diapers can increase how much is absorbed.
  • Can I put it on my face or my baby's diaper area?
📖 Read our full Fluocinolone Topical guide →

🕸️ Concept Web — How Fluocinolone acetonide 0.25 MG/ML / neomycin sul... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fluocinolone acetonide 0.25 MG/ML / neomycin sulfate 5 MG/ML Topical Cream RxCUI 1191359

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Fluocinolone 25126
    • Neomycin 7299
    • Fluocinolone / neomycin 687351
    • Fluocinolone acetonide 4461
    • Neomycin sulfate 7300
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Neo-Synalar 1542990
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluocinolone / neomycin Topical Cream 379383
    • Fluocinolone acetonide / neomycin sulfate Topical Cream 2649255
    • Fluocinolone / neomycin Topical Product 1165636
    • Fluocinolone acetonide / neomycin sulfate Topical Product 2662161
    • Fluocinolone / neomycin Topical Cream [Neo-Synalar] 1542992
    • Fluocinolone acetonide / neomycin sulfate Topical Cream [Neo-Synalar] 2659024
    • Neo-Synalar Topical Product 1542993
    • Topical Cream 316982
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fluocinolone acetonide 0.25 MG/ML SCDC · 1191314
  • Neomycin sulfate 5 MG/ML SCDC · 1191358
  • Fluocinolone / neomycin Topical Cream SCDF · 379383
  • Fluocinolone acetonide / neomycin sulfate Topical Cream SCDFP · 2649255
  • Fluocinolone / neomycin Topical Product SCDG · 1165636
  • Fluocinolone acetonide / neomycin sulfate Topical Product SCDGP · 2662161

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1191359 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
43538-0940-60 1 TUBE in 1 CARTON (43538-940-60) / 60 g in 1 TUBE Neo-Synalar Eurofarma, Inc. 1963-06-11
43538-0940-99 4 TUBE in 1 CARTON (43538-940-99) / 3 g in 1 TUBE Neo-Synalar Eurofarma, Inc. 1963-06-11
Observed labelers: Eurofarma, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.